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Background/aim: Due to nanomaterials’ potential benefits for diagnosis and treatment, they are widely used in medical applications
and personal care products. Interaction of nanomaterials, which are very small in size, with tissue, cell and microenvironment, can
reveal harmful effects that cannot be created with chemically identical and larger counterparts in biological organisms. In this review, a
challenge for future medicine, nanotoxicity of nanomaterials is discussed.
Materials and methods: A detailed review of related literature was performed and evaluated as per medical applications of nanomaterials
their toxicity.
Results and conclusion: Most authors state “the only valid technology will be nanotechnology in the next era”; however, there is no
consensus on the impact of this technology on humankind, environment and ecological balance. Studies dealing with the toxic effect of
nanomaterials on human health have also varied with developing technology. Nanotoxicology studies such as in vivo-like on 3D human
organs, cells, advanced genetic studies, and -omic approaches begin to replace conventional methods. Nanotoxicity and adverse effects
of nanomaterials in exposed producers, industry workers, and patients make nanomaterials a double-edged sword for future medicine.
In order to control and tackle related risks, regulation and legislations should be implemented, and researchers have to conduct joint
multidisciplinary studies in various fields of medical sciences, nanotechnology, nanomedicine, and biomedical engineering.
Keywords: Nanotechnology, nanotoxicity, bio-nanomaterials, future medicine

1. Introduction
As humanity stepped into the 21st century from the
beginning of the 1990s, it began to encounter dozens of
new invisible and unknown concepts that would lead to
huge growths and developments like nanotechnology.
Nanotechnology has become a worldwide billiondollar industry by producing high-volume, commercial
nanomaterials (NMs), including fullerenes, quantum
dots (QDs), carbon nanotubes (CNs), and metal-oxide
nanoparticles (NPs). Nanotechnology continues to take
part in many applications in all areas of human activities
(health, food and nutrition, water treatment, production
and engineering, etc.) and in our daily life. It is becoming
increasingly important due to its beneficial effects on
important issues such as energy production, application
to technological devices and consumer products to
gain new features. Due to its potential benefits for
diagnosis and treatment, it has been widely used in
healthcare and personal care products. As of 2014, it
was reported that 6214 organizations from 32 countries

used nanomaterials in 1814 consumer products, most
of which (42%) were shown to be in the field of health
[1]. The “nanodatabase” is an inventory of commercially
marketed products containing nanoparticles designed in
the European consumer market, and includes more than
3000 products. According to the data of this inventory,
the most usage area is in the health category (close to
2000), more than 900 of them are cosmetics and personal
care products. The most widely used nanomaterial
for these purposes is silver, followed by titanium and
silicon [2]. In parallel with these intense developments
in nanotechnology, the issue of whether nanomaterials
have toxic effects has begun to come to the agenda.
Interaction of nanomaterials, which are very small in
size, with tissue, cell and microenvironment, can reveal
harmful effects that cannot be created with chemically
identical and larger counterparts in biological organisms.
Nanotechnology is discussed in this review, as it is an
important challenge and a double-edged sword that
awaits future medicine.
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2. Nanotechnology
Nanotechnology is a multidisciplinary field of science,
where unique phenomena enable new applications, to
design and synthesize products and applications based
on the synthesis of nanometer (10-9 meters) molecules.
As the particle size decreases at the nanoscale, it is known
that the physical properties of the particles can be altered,
and features such as resistance, conductivity, durability,
lightness, reactivity, longevity and large surface sizes are
gained. In this way, it can be used to create new products
and applications [3].
3. Nanomaterial
3.1. Definition
Nanomaterial is a structure that is the size of a virus particle
and at least one size (height, width or length) less than 100
nanometers (10−7 meters). They are classified according to
their characteristics such as size, dimension (0, 1, 2, 3D),
content (carbon-based, inorganic-based, organic-based,
composite-based etc.), composition, shape (nanoparticle,
nanofiber, nanostick, nanotube etc.), and source (natural,
synthetic).
The most commonly used nanomaterial types are
the nanoparticle, the all three dimensions of which are
equal to each other and smaller than 100 nanometers, the
nanofiber, the two dimensions of which are equal to each
other and the other dimension is different from nanosize,
and the carbon nanotubes with cylindrical molecules

consisting of carbon atoms, as small as 1 nm in diameter
and several micrometers in length [1]. Nanoparticles can
be classified as organic-inorganic or can be classified in
different ways according to different features such as size,
molecular structure, and form of production. Hierarchy of
terms related to nanomaterials showed in Figure 1.
3.2. Composition of nanomaterials
3.2.1. Metal-based
Metal-based NPs are an important class of NPs that are
synthesized due to their functions as semiconductors,
electroluminescent and thermoelectric materials [4].
These antibacterial NPs have been used in drug delivery
systems to reach areas previously unavailable to access
by conventional medicine in biomedicine. Recently,
interest and development in nanotechnology have been
increased, and so many studies have been conducted to
evaluate whether the original features of these NPs such
as large surface area to volume ratio, negatively affect the
environment [5]. Researchers have since determined that
various metal and metal-oxide NPs have many hazardous
effects on the cells such as oxidation and breakage of
DNA, mutations, change of morphology, decreased cell
viability, stimulated apoptosis and necrosis, and reduced
proliferation [4].
3.2.2. Carbon-based
Typical carbon-based nanomaterial is carbon nanotubes.
Carbon nanotubes were first discovered by Iijima and
Ichihashi [6] and Bethune et al [7] in 1993. Carbon

Nanomaterial
1, 2 or 3 external dimensions in
the nanoscale

Nanoparticle

Nanoﬁbre

3 external dimensions
in the nanoscale

Nanorod

2 external dimensions
in the nanoscale

Nanotube

Solid nanoﬁbre

Hollow nanoﬁbre

Nanoplate
1 external dimensions
in the nanoscale

Nanowire
electrically conducting or
semi-conducting nanoﬁbre

Figure 1. Hierarchy of terms related to nanomaterials.
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nanotubes can show significant electrical conductivity [8].
Also, their tensile strength [9] and thermal conductivity
[10] are outstanding due to their nanostructure and the
strength of the bonds between carbon atoms. Because of
these properties of CNs, they can be utilized in many areas
of technology from biomedicine to nanoelectronics.
3.2.3. Metal-oxide
Metal-oxide NPs are used as industrial catalysts. TiO2
nanoparticles may disrupt insulin response in Fao cells
and cause pregnancy complications in some animal model
studies [11, 12]. Studies have showed that other metaloxide nanoparticles have adverse effects on reproduction
and neonatal development [13, 14].
3.2.4. Quantum dots
Quantum dots are engineered nanoscale crystals that can
transport electrons and they can covert a spectrum of light
into different colors. Quantum dots make possible to study
cell processes and may notably improve the diagnosis and
treatment of diseases such as cancers [15,16]. Some studies

Chemical
composition

showed that QDs have effects on reproductive dysfunction,
TH signaling, estrogen receptor activation, and endocrine
impairing activity [17–19]. Biological effects due to
chemical composition of nanomaterials are summarized
in Figure 2 [20–25].
4. Nanoparticle
The International Organization for Standardization (ISO)
defines the nanoparticle as a nanoobject with all three
external dimensions in the nanoscale of about 1 to 100 nm
[26, 27]. They can be found naturally in nature, but they
are also produced industrially.
5. Nanotoxicity
5.1. Definition
Nanotoxicology focuses on determining the adverse
effects of nanomaterials on human health and the
environment. Nanotoxicology searches for establishing
and identifying the harms of engineered nanomaterials

Physicochemical property

Toxicokinetic findings

Incorporation of 1% (w/w)
manganese doping into
titania particles

Increase in UVA absorption
and reduction in free radical
generation via surface reactions

Carbon nanomaterials

Different geometric
structures exhibit quite
different cytotoxicity in
vitro

The cytotoxicity follows a
sequence order:
SWNTs>MWNTs>quartz>C60
on alveolar macrophages
isolated from guinea pigs

Metal traces associated
with the commercial carbon
nanotubes

A dose- and time-dependent increase of
intracellular reactive oxygen species
and a decrease of the mitochondrial
membrane potential in rat macrophages
(NR8383) and human A549 lung cells

More reactive as compared
to purified carbon
nanotubes

Quantum dots core
metalloid complexes of
Cadmium (Cd) and
Selenium (Se)

They can cross the blood–brain barrier
and placenta, and is systemically
distributed to all bodily tissues, with
liver and kidney being target organs of
toxicity

Cd is a probable carcinogen.
A marked impact on the local
ecosystem resulted from
elevated environmental
concentrations of Se

Ag, MoO3, Fe3O4, Al,
MnO2 and W (Tungsten)

Ag was highly toxic whereas, MoO3
moderately toxic and Fe3O4, Al, MnO2
and W (Tungsten) displayed less or no
toxicity at the doses tested on in vitro
rat liver derived cell line (BRL 3A)

Reduced cell proliferation
and death

La0.7Sr0.3MnO3 (LSMO) nanoparticles
doped with cerium (La0.7-x
CexSr0.3MnO3 where 0 x 0.7) and
La1 ySryMnO3 nanoparticles with
different values of y (La/Sr ratio)

Low cytotoxicity in Ce-doped samples
as well as in samples with reduced La/
Sr ratio as revealed by in vitro studies
on HT-1080 (human fibrosarcoma) and
A431 (human skin/carcinoma) cells

Improved cell proliferation
upon Ce doping

Figure 2. Biological effects due to chemical composition of nanomaterials.
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and requires a multidisciplinary team approach including
toxicology, biology, chemistry, physics, material science,
geology, exposure assessment, pharmacokinetics, and
medicine [28]. Engineered nanomaterials are used in
many fields such as automotive and aerospace (car
tires, glass, fuel cells), agriculture (food processing,
production, packaging, storage), construction (cementbased material, insulation, exterior, self-cleaning glass and
paint, etc.), energy (thermoelectric, solar cells, long-life
batteries, fossil fuel, nuclear energy), health and medicine
(diagnosis, treatment, regenerative medicine, surgery,
implant), information and communication (flat TV
screens, electronic devices), security and defense industry
(detection, protection, localization, unmanned combat
vehicles), textiles (self-cleaning or stain-free products),
cosmetics (sunscreens, toothpaste, make-up products),
etc. [29]
On the one hand, while it is used in the diagnosis
and treatment of diseases in the field of biomedicine,
doubts have begun to arise that it may cause diseases. The

painful experience of human beings with carcinogenic
products such as tobacco products and asbestos, which
they initially thought innocent, also caused a question
mark for NPs. Because some NPs have long, thin, fibrous
structure asbestos-like, show fibrogenic and toxic effects
“Can nanoparticles be asbestos of the future?” caused the
question to be asked [30].
Factors such as exposure time, dose, aggregation
and concentration, particle size and shape, surface area
and charge play a key role in the toxicity assessment of
nanomaterials [31].
5.2. Factors
5.2.1. Size
There are several ways that size can affect the toxicity
of a nanoparticle and showed in Figure 3 [32–37]. For
example, the reduction in size of the nanomaterials results
an increase in the particle surface area. This causes more
molecules to bind to the surface area, so results in an
increase in toxic effect [38]. Particles of different sizes can

Physicochemical property

Toxicokinetic findings

Biological effects

15 nm gold NPs

Most widespread organ
distribution including
blood, liver, lung, spleen,
kidney, brain, heart,
stomach in mice

Biodistribution of the
nanoparticles

15-50 nm gold NPs

Pass blood–brain barrier
(BBB) in mice

Blood brain barrier
(BBB) permeability

45-50 nm gold NPs

Activation of membrane
receptors in SK-BR-3
cells

50 nm gold NPs

Maximum uptake
by Hela cells

50 nm quantum dots

Efficient
receptor-mediated
endocytosis
in Hela cells

1-10 nm silver NPs

Penetrate inside the
bacteria

Size

Exclusively attach to
HIV-1

Figure 3. Biological effects due to size of nanomaterials.
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deposit in various places of the lungs and are cleared from
the lungs at different rates [39].
5.2.2. Particle surface, surface chemistry and charge
Extended surface area and fine surface structure of the
NMs are properties that help better interaction between
microenvironment and nanomaterial biologically.
Nanomaterials are covered with coatings and according to
their function; they can be positive or negative charged.
Electron and atomic force microscopes can be utilized for
topographic characterization, so surface chemistry can
be evaluated. Studies have showed that these factors can
affect the toxicity rate of nanoparticles [40,41]. Biological
effectsare showed in figure 4 [32, 42–50].
5.2.3. Dosage
Nanomaterials are known to have dose-dependent toxic
effects by inhalation, and there are many publications
regarding this issue. Recent studies that the evaluation
of mass concentration measurement within the scope of
toxicological dosing alone gives false results and does not
explain the whole relationship between the nanomaterials
and exposed tissue [51].
5.3. Exposure routes and ADME
Inhalation is the most common and best-known route
among nanomaterial exposure ways. In addition, they can
also enter the human body through the skin, digestion or
injection.
Nanoparticles are thought to play a role in the
development of some diseases by acting on the lungs
and other systems with various pathogenic mechanisms.
Particles smaller than 0.1 μm can reach distal airways
with respiratory units [52]. The inhaled NPs come to
the respiratory epithelium and pass through the pores in
the alveoli-capillary membrane, first to the interstitium
and then to the systemic circulation through blood and
lymphatic circulation. In experiments in mice, it has been
demonstrated experimentally that NPs applied into the
trachea pass into systemic circulation in this way [53].
In studies conducted to reveal the possible toxic
effects of NPs on human health, NPs of different character
were applied in different ways (inhalation, intratracheal,
intravenous, intraperitoneal, etc.) and in different doses,
and parameters such as transition to systemic circulation
in living organisms, accumulation in tissues, inflammation
in tissues, other immune responses and excretion of NPs
from the body have been studied. In a study conducted
in five healthy volunteers, it has been observed that ultrafine carbon particles smaller than 100 nm quickly enter
the systemic circulation in a short time like 10 minutes
after inhalation and maintain their level in the systemic
circulation for about an hour [54]. In a study in mice,
the 60-day tissue distribution of magnetoelectric NPs of
different sizes administered intravenously was investigated
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by electron microscopy, in approximately one week all NPs
reached peak deposition in the lung, but the elimination
of large particles of 600nm from the lung was slower than
small particles [55].
Nanoparticles with short size and spiral structure
entering the body are destroyed in tissues by macrophages.
However, nanotubes with high aspect ratio reach to the
pleura like asbestos fibers and accumulate around the
pores there. These fibrous particles cannot be phagocyted,
and proinflammatory, genotoxic mitogenic mediators are
released by mesothelial cells. Thus, an inflammation and
damage process begin [56]. This inflammation that starts
in the lungs, on the one hand causes pulmonary endothelial
dysfunction and stimulation of pulmonary reflexes, on
the other hand activates the platelets and increases the
thrombotic activity. In addition, inflammation in the
vascular area can cause vascular endothelial dysfunction,
causing cardiovascular disorders such as impaired heart
rate and rhythm, atherosclerotic plaque formation and
rupture [52]. Nanoparticles stimulate both natural
and acquired immunity, and causing an inflammatory
response. Stimulation of both the macrophage/monocyte,
neutrophil, dendritic, natural killer cells responsible for
natural immunity and the dendritic cells and lymphocyte
responsible for acquired immunity, proinflammatory
cytokines, lipid mediators and free radicals are released,
resulting in neutrophilic or eosinophilic lung inflammation.
Immunomodulatory effects of NPs may differ according
to their physicochemical properties such as size, surface
structure, electric charge, aggregation ratio [31].
6. Entry routes of nanoparticles into the human body
It is inevitable that the human being, who is a social entity,
has contact with the nanomaterials around it. A lot of
research has been conducted about nanomaterials that
have damage different parts of the body. Nanomaterials
most often enter the body through the respiratory tract
and are in intensive contact with the lungs. The entry of
nanomaterials into the body is also very common through
skin contact and the gastrointestinal tract. Also, implants
and injections allow nanomaterials to enter the body [57].
6.1. Inhalation exposure
The size of the nanoparticles, its resistance to gravity, and
its spreading pattern determine the area in which it will
settle in the respiratory tract. Nanoparticles absorbed into
the body through the respiratory tract cleaned in different
parts of the respiratory system by mucociliary layer and
macrophages or they clustered in the lungs and spread
to the body with blood circulation [58]. Sajid et al. stated
that 33% of the inhaled nanoparticles can be removed
from the body by the defensive system of the respiratory
tract [59]. Animal studies reported that carbon nanotubes
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Shape

Surface area/
volume ratio

Physicochemical property

Toxicokinetic findings

Biological effects

Open-ended Singlewalled carbon
nanotubes (SWNTs)

Efficient blocking of
ion channels
in CHO cells

Spherical shaped closeended SWNTs are
comparatively less
reactive

Spherical gold NPs

Higher uptake by Hela
cells

Rod-shaped gold NPs
showed less uptake

Carbon particles

Stimulated human platelet
aggregation in vitro and
accelerated the rate of
vascular thrombosis in rat
carotid arteries

Biological reactivity: mixed
carbon nanoparticles
(MCNs) single-walled carbon
nanotubes
(SWNTs)>multiwalled carbon
nanotubes (MWNTs)

TiO2 (300 cm2 surface
area)

Increased lymph-node
burdens and
Inflammation

More reactive in rats as
compared to BaSO4
(200 cm2 Surface area)

TiO2 and BaSO4 with
same surface area

Inflammatory effects
were similar

Inflammation

Ultrafine carbon black
particles (270 m2/g
surface area)

Cause greater
pulmonary toxicity
in rats

Increased reactivity in
comparison with largersized carbon black particles
(22 m2/g surface area)

Drug delivery
applications to brain in
rats

Neutral NPs and low
concentration anionic
NPs Cationic NPs

Surface charge

Toxic effect at the
blood brain barrier
in rats
Superior uptake rates
as compared to neutral
or cationic NPs at the
same concentrations in
rats

Anionic NPs at lower
concentrations
Positive surface
charged poly
(amidoamine)
dendrimers

Deposition into tissues is higher
than neutral surface dendrimers
in B16 melanoma and DU 145
human prostate cancer mouse
tumor model

Higher deposition
in tissues

Coating of respirable
quartz surface with
aluminum lactate or
polyvinyl-pyridine-Noxide (PVNO)

Inhibits DNA strand
breakage and formation of
8-hydroxy-deoxyguanosine
in human lung
epithelial cells

Reduction in toxicity

Figure 4. Biological effects due to shape, surface area/volume ratio and charge of nanomaterials.

produce fibrosis, inflammation and granuloma in the
lungs, and these toxic effects in the lungs cause systemic
cardiovascular disorders [60]. Besides, it was stated that

the inhaled nanoparticles can reach different organs of the
body including the brain, and the evaluation of the risk of
association with prostate cancer was investigated [61,62].
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6.2. Dermal exposure
The three effective factors in the absorption of nanoparticles
from the skin are the physicochemical properties of
nanoparticles, the physicochemical properties of the tool
dispersing the penetrating molecule, and the location and
skin conditions. Cosmetic cream, lotion and toothpaste
are nanoparticle-based tools that are often used in skin
exposure. Nanoparticles usually accumulate in the stratum
corneum and dermis [63,64]. It is also stated that some of
the nanoparticles absorbed from the skin can leak into the
bloodstream.
6.3. Ingestion
Nanoparticles are effectively absorbed from the
gastrointestinal tract directly or through secondary
ingestion of inhaled particles. It is important to note
that nanoparticles with a high probability of accidental
ingestion such as metal compounds and pesticides. This can
often be ignored, as it is thought to occur only deliberately
or because of gross negligence. Also, poor absorption of
nanoparticles from the intestines and metabolism in the
liver contributes to this situation [65,66].
7. Medical use of nanoparticles
As a relatively new subdivision of medical sciences,
nanomedicine takes place among rising disciplines in
parallel to the nanotechnological developments. Thanks to
the potential of modification of nanoparticle characteristics
nanoparticles have a wide range of applications. Therefore,
a number of nanoparticles are currently utilized or being
studied in certain medical areas such as treatment of
diseases or malignancies, surgery, medical implants,
smart drug delivery systems, gene delivery, diagnosis/
imaging, tissue engineering, regenerative medicine, and
antimicrobial resistance and etc.
7.1. Cancer diagnosis and treatment
The use of nanoparticles in cancer diagnosis, imaging
in particular, and treatment increase everyday. In order
to reveal tumor sites more accurately quantum dots are
utilized with magnetic resonance imaging. On the other
hand, cancer biomarkers can be sensed by nanoparticle
based test chips such as lab on a chip for noninterventional
cancer diagnosis at the earliest stage [67].
Carbon nanotubes are used for revealing mutations
in DNA and detection of biomarkers. Dendrimers
and nanoparticles can be utilized as contrast agents
for imaging, and in mechanisms of smart (targeted or
controlled release) drug delivery [68].
Lantanide (Gd3+ and Yb3+) functionalized gold
nanoparticles were used in vivo for both imaging (MRI
and CT) and for therapeutic (photothermal) purposes.
Additionally, ion-doped nanomaterials are used in bioimaging medical area [69].
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7.2. Gene therapy
As a widely studied area gene therapy is dedicated to
prevention and treatment of genetic disorders by correction
of defective genes. This can be performed through delivery
or replacement of the repaired or correct gene by several
methods. This approach has potential use certain types of
cancers, infections, cardiovascular diseases, autoimmune
diseases, and monogenic diseases such as hemophilia.
7.3. Treatment of neural degeneration
As in other treatment strategies, treatment of degenerative
diseases or posttraumatic pathologies focuses on
regeneration and protection of neural tissue, and guided
axon growth. Therefore, nanomedical applications
are promising in terms of treatment of Parkinson’s,
Alzheimer’s diseases, and regeneration of axonal damage.
Use of nanoparticles showing high affinity for circulating
amyloid-β (Aβ) subtypes potentially suppress symptoms
of Alzheimer’s disease [70].
7.4. Tissue engineering
This is a commonly known topic by professionals of
regenerative medicine, nanomedical and biomedical
engineers. It has applications regarding repair or reproduce
damaged tissues by various forms and compositions of
biocompatible, biodegradable nanomaterial-based bioscaffolds with minimum side effects.
7.5. Antimicrobial activity
A number of metallic nanoparticles are known to show
antimicrobial activity, which can be used in combination
of medications to reduce antibiotic resistance, as well.
Gold, silver, zinc oxide, and etc. nanoparticles take place
among such agents. These nanoparticles are also utilized
to produce a number of surgical or implantable devices to
the body [71].
7.6. Orthopedic implants
A number of implants such as bone tissue engineering
materials, nanostructured implantable materials, and
those produced by surface modification or coating are
applied in orthopedic surgeries. Synthetic and natural
polymers take place among common nanomaterials
used for tissue engineering of bone/cartilage. These
are collagen, hyaluronic acid, chitosan, titanium alloys,
ceramic-coated metal-oxides (such as alumina, zirconia
and titania), hydroxyapatites, and carbon nanomaterials
such as graphene or diamond [72].
In order to achieve bioactivity, better mechanical
properties and higher osteo-conductivity for faster and
more efficient healing process, carbon nanocomposites
containing ceramic or polymer matrix are used [73].
7.7. Dental application
Nanomaterials applied in dentistry are mostly
antimicrobial,
therapeutic
and
reinforcemental
materials. They also used for polishing the enamel surface,
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in dental fillings and in dental implants. Composites are
carbon nanotubes, graphene, hydroxyapatite, iron oxide
Zirconia, silica-based nanomaterials, titanium and silver
nanoparticles [74,75].
7.8. Cardiovascular applications
Natural and synthetic nanomaterials are also used in heart
tissue bioengineering. For biocompatibility, alginate and
collagen are frequently used, while synthetic polyesters
such as poly-L-lactic and poly (lactic co-glycolic) acids are
commonly used. In addition, carbon nanotubes are used
for coating stents and coronary implants [76].
7.9. Dermal applications
Skin implants that enhance tissue repair process are
frequently used in wound healing. Although this frequency
varies according to the clinical need, it consists mostly of
poly (lactic-co-glycolic acid)/chitin markers that mimic
human keratinocytes and fibroblasts as autologous skin
grafts [77].
8. Toxic effects of nanoparticles on systems
Since nanoparticles enter the body in three main ways, it is
known by experimental studies that it causes toxic effects
in different systems. This section describes the toxic effects
of nanomaterials on systems mostly by experiments on
animals.
8.1. Circulatory system
Nemmar et al. detected cardiac oxidative stress and DNA
damage in a study of intravenous administration of iron
oxide nanoparticles in mice [78]. Magaye et al. reported
a cardiac toxicity-arrhythmia in the study of intravenous
administration of Ni nanoparticles in rats and observed
toxic effects in organs such as liver, spleen and lung [79]
8.2. Digestive system
Arefian et al. reported that 100 ppm zirconia oxide
nanoparticles cause damage to the liver in rats [80]. Also,
iron oxide nanoparticles cause liver toxicity in mice [81].
8.3. Endocrine system
Yousefi et al. reported that oral form iron oxide
nanoparticles cause irregularities in thyroid hormones in
rats [82].
8.4. Immune system
Xu et al. reported that Ti02 nanoparticles in mice caused
a serious increase in the number of white blood cells [83].
Besides, iron oxide nanoparticles cause an increase in the
number of white blood cells, and the liver and spleen are
the most affected organs immunologically [84].
8.5. Respiratory system
Cai et al. reported that metal nanoparticles (Cobalt oxide,
nickel oxide, titanium oxide) applied by oropharyngeal
aspiration cause toxicity in the lungs [85]. Similarly,
Sadeghi et al. determined that iron oxide nanoparticles
cause lung toxicity in rats [86].

8.6. Urinary system
Saranya et al. stated that zinc oxide, iron oxide and copper
nanoparticles cause toxic effects on kidney cells in several
monkeys, pig and bovine [87]. Besides, Fartkhooni et al.
reported that TiO2 nanoparticles injected intraperitoneally
cause degeneration in rat kidneys [88].
8.7. Nervous system
Studies were carried out on animal ears and eyes related
to vision and hearing toxicity, and minimal toxicity was
detected or no toxicity was detected generally [89,90].
8.8. Reproductive system
Mozaffari et al. determined that zinc oxide nanoparticles
injected intraperitoneally in mice caused a decrease and
loss in seminiferous tubule cells [91]. Besides, Kong et al.
stated that nickel nanoparticles cause a decrease in FSH
and LH hormone levels and changes in sperm motility in
rats [92].
9. Toxicity mechanisms of nanoparticles
Mechanical effects due to the physicochemical properties
of nanoparticles cause toxicity. The basic mechanism of
toxic effect formation is reactive oxygen species (ROS)
formation, either directly or indirectly. ROS formation
is toxic in vitro by multiple mechanisms in the cell [93].
ATP synthesis in mitochondria occurs as a result of the
reduction of molecular oxygen to water. During this event
superoxide anions and radicals containing different oxygen
are formed. ROS formed are known as hydroxyl radical,
single oxygen, hydrogen peroxide and superoxide anion
radicals [94]. Overproduction of these radicals, which
play a role in mitogenic response and cellular signaling
and leads to disruption of physiological functions in cells
[95,96]. The damage caused by nanomaterials to the cell is
cytotoxic and genotoxic (Figure 5). Since nanomaterials
have small dimensions, they cause more ROS production
due to their specific surface area and high surface reactivity
[97].
It is revealed in studies in living tissues such as human
erythrocytes and skin fibroblasts that different types of
nanomaterials cause toxicity by ROS activation [98].
Kim et al. determined that nano-Ag causes oxidative
stress and genotoxicity in cultured living tissue also Mei
et al. determined that nano-Ag creates mutations by
increasing ROS formation in mice [99,100]. Hsin et al.
reported that nano-Ag caused cytotoxicity by activating
ROS in the mitochondrial pathway [101]. Akhtar et
al. reported that silica nanoparticles cause cytotoxicity
in the cell membrane and cause cytotoxicity in mouse
embryonic fibroblasts through the production of ROS
and lipid peroxidation of nano-CuO [102,103]. Girgis et
al. proposed that nano-Au caused toxicity by causing an
increase in oxidative stress in mice [104]. Shvedova et
al. reported that single-walled CNTs cause cytotoxicity
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Figure 5. ROS and nanomaterial toxicity

in keratinocytes and bronchial epithelial cells leading to
ROS production and mitochondrial dysfunction [105].
Winnik and Maysinger determined that quantum dots
cause cytotoxicity by increasing ROS production [106]. It
is reported that cytotoxic effect of nano-ZnO in human
bronchial epithelial cells by increasing ROS production
[107]. Nano-FeO was reported to have a cytotoxic effect by
increasing ROS formation and apoptosis, also comparing
the cytotoxic effects of nano- Ti02, Co3O4, ZnO and CuO
in hepatocyte cells, it was found that the most cytotoxic
effect was in nano-CuO [108,109].
Other factors contribute to the toxicity of nanomaterials,
such as surface area, surface coating, molecular size, shape,
oxidation status, solubility and degree of aggregation and
agglomeration [110]. It is determined that increasing the
toxic effect of nanoparticles is directly proportional to the
decrease in size. Yoshida et al. reported that amorphous
nanosilica causes toxicity in the human cell, both by
increasing ROS formation and by damaging DNA [111,112].
Besides, only in the evaluation based on its size, the smaller
the nanoparticles, the more toxic it is to the organs [113].
Studies were reported that wire-shaped nanomaterials cause
DNA damage and toxic effects through ROS production
[114]. Studies were carried out on the effect of the shape of
nanomaterials on toxicity, it was reported that the difference
in shape does not make a critical difference in the toxic effect
of nano Au in human skin keratinocyte cells [115]. On the
contrary, a study on nano-ZnO crystals, it was reported
that the hexagonal crystals have a more toxic effect than the
rod-shaped ones [116]. Biocompatibility and nanoparticle
contact area are directly proportional. A study was carried
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out in zebrafish embryos by Ispas et al. observed that
dendritic ones were more toxic than spherical ones [117].
One of the nanomaterials commonly used in drug delivery
systems is silica. Nanosilica causes different toxic effects in
different pore volumes [118]. Oh et al. reported that the
toxicity of the cationic charged nanosilica-titania particles
is high [119]. Studies were carried out about size, shape
and the relationship of surface parts of quantum dots with
nanotoxicity [106,120]. In toxicity studies on fullerenes, the
groups bound to the surfaces of these nanomaterials have a
determining role in the effect of toxicity. Since it was stated
that fullerenes cause cytotoxicity by producing free oxygen
radicals, there are also fullerenes with antioxidant activity
by adding malonyl groups to their surface [110]. Studies
on the effect of nanomaterial solubility on toxicity were
conducted. Studer et al. reported that ZnO nanoparticles
have a less toxic effect than soluble copper metal [120].
Shen et al. determined that the dissolution of nano-ZnO
cells is effective in the important emergence of the cytotoxic
effect [121]. Mahto et al. reported that quantum dots
dissolve in water, increasing ROS production and causing
cytotoxicity [122]. UV and visible light have affected the
stabilization of nano-TiO2 and nano-ZnO materials.
In this way, photoexcitation through electrons causes
toxicity [123]. Studies were carried out on graphene and
aggregation toxicity used in many biomedical fields such
as drug delivery systems, biosensors and labeling [124].
Also, Kim et al. noted the importance of agglomeration and
aggregation in nano-Ag induced toxicity [99].
It continues to be researched in different organisms
such as rodents, humans and plants in toxicity studies.
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Multiple areas differ according to the type of nanomaterial
carbon and metallic nanomaterials are frequently
used in the engineering area. Besides, the use of metal
nanomaterials in cosmetics, medicine and food is also a
common area.[125]. Sun creams and lotions containing
nanotitanium and nanozinc show toxic effects on the skin
and the environment depending on the frequency of use
[126]. It is shown by the researchers that nanocopper oxide
is effective in cytotoxicity and DNA damage, also carbon
nanotubes have a toxic effect on cells [127,128].
10. Toxicity testing
In vitro experiments are performed more frequently
than in vivo experiments, and questions about dosing are
important in determining toxicity. One of the models used
in the toxicity test is in vitro sedimentation diffusion and
dosimeter. This model lies in the clear distinction between
exposure (concentration in the cell environment), the
dose accumulated on the cell surface and the cellular dose.
Information about the time to release a given dose allows us
to evaluate the dose rate as a determinant of response [129].
Since in vitro methods that determine cell viability and
proliferation are frequently used in determining toxicity,
methods such as gene expression analysis, genotoxicity
detection and in vitro hemolysis are also used. Additionally,
there are microscopic and spectroscopic methods for
the evaluation of physicochemical structure in the cell
such as scanning electron microscopy/energy dispersive

X-ray spectroscopy (SEM-EDX), transmission electron
microscopy (TEM), atomic force microscopy (AFM),
video-enhanced differential interference contrast (VEDIC)
microscopy and fluorescence spectroscopy. The combined
use of all these tests makes it easier to detect nanotoxicity
[130]. A concise list to summarize previously conducted
studies regarding currently used toxicity tests, the purpose
of the tests, and the target nanomaterials is presented in
Table [131–147].
Exposure to nanoparticles through the respiratory tract
often causes adverse effects on the lung. There are many
studies on determining the detection of lung toxicity, and
organ-on-a-chip studies have been important in recent
years. Zhang et al. evaluated nanotoxicity by better imitating
human responses with the chip in a 3D human lung model
similar to in vivo. Also, this study showed the importance of
organ-based toxicity with realistic models [148]. Studies in
mouse placenta determined that nanoparticles pass through
the placenta and show a toxic effect. Yin et al. reported that
chip and TiO2 nanoparticle exposure-related studies in the
3D human placenta model might have similar toxic effects
[149]. Besides, nanotoxicity studies were carried out with
the integration of a cell-on-a-chip (CoC) with a microfluidic
system [150].
11. Concerns, future aspects and concluding remarks
Studies utilizing nanotechnology have been continuing
rapidly in the last twenty years, which boosts related

Table. A summary of literature related toxicity tests of nanomaterials [131-147].
Toxicity test

Purpose

Nanomaterials

Transmission electron microscopy

Determination of intracellular localization TiO2, silver,fullerene [131–133]

Light microscopy

Physicochemical properties

Singled walled carbon nanotubes, silver
[132,134]

Hemoglobin estimation

Hemolysis

SiO2 [135]

Micronucleus test

Genotoxicity

Different types of nanoparticles [136]

Commet assay test

DNA damage

Metal, metal oxide nanoparticles [137]

Lactate dehydrogenase

Carbon nanoparticles [138,139]

Tetrazolium salts

Carbon nanoparticles, fullerenes [140,141]

Alamar Blue

Quantum dots [142]

Propidium iodide
Neutral red assay test
Caspase-3 activity
Acridine orange/ethidium bromide

Cell viability
Apoptosis

ROS production
Levels of glutathione peroxidase, catalase,
superoxide dismutase
Lipid peroxidation, vitamin E

Carbon nanoparticles [143,144]
Carbon nanotubes [140,145]
Silver nanoparticles [132]
Silver nanoparticles [146]
TiO2 [131]

Oxidative stress

Polymeric nanoparticles [147]
Singled walled carbon nanotubes [105]
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investment, industrial activities, marketing, and economic
planning. This results in increase of number of related good
and bad actors in the area. Each actor takes the heed of different
priorities that might be controversial to others. Medical
professionals considers biocompatibility, biodegradability
and effectiveness of nanomaterials as priority, while
professionals interested in industrial activities, marketing,
and economic issues may prioritize scaling up production
of new devices or nanomaterials, and decreasing costs and
timescales. This inconsistency also raises questions about
nanomaterials’ potential adverse effects. Since most authors
state that “the only valid technology will be nanotechnology
in the next era”, there is no consensus on the impact of this
technology on humankind, environment and ecological
balance. Following increasing regulatory demands
regarding use of nanomaterial-based medical devices and
advanced therapeutic medicinal products; governments
have installed certain institutional projects. Out of projects
investigating nanomaterials’ safety, the National Cancer
Institute in United States points out that “most engineered
nanoparticles are far less toxic than household cleaning
products, insecticides used on family pets, and personal
care products”. Similarly, European Union installed
BIORIMA (BIOmaterial Risk MAnagement) project that
aims developing an integrated risk management framework
for the safe handling of nano-biomaterials used in medical
applications, and to assess and manage certain factors
potentially arising from manufacturing and use of such
materials.
Studies dealing with the toxic effect of nanomaterials on
human health have also varied with developing technology.
Nanotoxicology studies such as in vivo-like on 3D human
organs, cells also advanced genetic studies are beginning to
replace conventional in vitro analytical methods [151,152].
In vitro testing methods might require assessment of
multiple challenging steps such as physicochemical
properties of nanomaterials, the environment-target cell,

cellular uptake and epigenetic interaction [153]. Omic
approaches; next generation sequencing, transcriptomics
and proteomics, have provided considerably more
information regarding the toxicity of the complex cellular
processes triggered by interaction of nanomaterials with the
microenvironment [154,155]. Also, an important point is
personalized toxicology. Possible genetic susceptibility to
toxicity of nanomaterials should also be carefully studied
under this topic [156]. The analysis of data obtained through
novel technological developments and nanotoxicological
studies is getting more and more difficult. In respect of
above discussed issues, extraordinary increase of use of
nanomaterial-based medical agents and devices come up
with a challenge for future medicine. Nanotoxicity and
adverse effects of nanomaterials in exposed producers,
industry workers, and patients make nanomaterials a
double-edged sword for future medicine. In order to
control and tackle related risks, regulation and legislations
should be implemented, and researchers have to conduct
joint multidisciplinary studies in various fields of medical
sciences, nanotechnology, nanomedicine, and biomedical
engineering.
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